Condition: Alzheimer's Disease (AD) · Mild Cognitive Impairment Due to Alzheimer's Disease · Alzheimer Disease Dementia · Sponsor: University College, London
A multicentre, interventional, multi-arm, multi-stage Phase 3 trial including randomisation, double blinding, placebo control evaluation of treatments for sustained clinical response (18 months) in symptomatic Alzheimer's Disease in a population representative of people with Alzheimer's disease in the UK.
This description comes directly from the study's public registry record.
Trial Management Team UCL InCTU · +44 (0)20 7670 4700 · mrcctu.adsmart@ucl.ac.uk
Always discuss trial participation with your own doctor first.
| Windsor Research Unit | Cambridge, United Kingdom | Recruiting |
| Two Bridges Research & Development Clinic | Chertsey, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07724132